Biologic effects of SMF and paclitaxel on K562 human leukemia cells.

In this study, we evaluated the ability of 8.8 mT static magnetic fields (SMF) to enhance the in vitro action of a chemotherapeutic agent, paclitaxel, against K562 human leukemia cells. We analyzed the cell proliferation, cell cycle distribution, DNA damage and alteration of cell surface and cell organelle ultrastructure after K562 cells were exposed to paclitaxel in the presence or absence of 8.8 mT SMF. The results showed that in the presence of SMF, the efficient concentration of paclitaxel on K562 cells was decreased from 50 to 10 ng/ml. Cell cycle analysis indicated that K562 cells treated with SMF plus paclitaxel were arrested at the G2 phase, which was mainly induced by paclitaxel. Through comet assay, we found that the cell cycle arrest effect of paclitaxel with or without SMF on K562 cells was correlated with DNA damage. The results of atomic force microscopy and transmission electron microscopy observation showed that the cell ultrastructure was altered in the group treated with the combination of SMF and paclitaxel, holes and protuberances were observed, and vacuoles in cytoplasm were augmented. Our data indicated that the potency of the combination of SMF and paclitaxel was greater than that of SMF or paclitaxel alone on K562 cells, and these effects were correlated with DNA damage induced by SMF and paclitaxel. Therefore, the alteration of cell membrane permeability may be one important mechanism underlying the effects of SMF and paclitaxel on K562 cells.

[1]  N Kumar,et al.  Taxol-induced polymerization of purified tubulin. Mechanism of action. , 1981, The Journal of biological chemistry.

[2]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[3]  W. Mellado,et al.  Taxol: mechanisms of action and resistance. , 1986, Annals of the New York Academy of Sciences.

[4]  B. Bhattacharyya,et al.  Kinetic and thermodynamic analysis of taxol-induced polymerization of purified tubulin. , 1987, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[5]  B. Greenebaum,et al.  An increase in the negative surface charge of U937 cells exposed to a pulsed magnetic field. , 1991, Bioelectromagnetics.

[6]  I. Ringel,et al.  Direct photoaffinity labeling of tubulin with taxol. , 1992, Journal of the National Cancer Institute.

[7]  S. Horwitz,et al.  Mechanism of action of taxol. , 1992, Trends in pharmacological sciences.

[8]  M. Jordan,et al.  Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Searle,et al.  In vitro cytotoxicity against human cancer cell lines during pulsed magnetic field exposure. , 1994, Anticancer research.

[10]  B. Hellman,et al.  The concepts of tail moment and tail inertia in the single cell gel electrophoresis assay. , 1995, Mutation research.

[11]  F. Marinelli,et al.  Intramembrane protein distribution in cell cultures is affected by 50 Hz pulsed magnetic fields. , 1997, Bioelectromagnetics.

[12]  G. A. Hofmann,et al.  Electroporation therapy: a new approach for the treatment of head and neck cancer , 1999, IEEE Transactions on Biomedical Engineering.

[13]  J. Parker,et al.  In vivo enhancement of chemotherapy with static electric or magnetic fields. , 2000, Bioelectromagnetics.

[14]  I. Belyaev,et al.  ELF magnetic field affects proliferation of SPD8/V79 Chinese hamster cells but does not interact with intrachromosomal recombination. , 2001, Mutation research.

[15]  G. Gundersen.  Evolutionary conservation of microtubule-capture mechanisms , 2002, Nature Reviews Molecular Cell Biology.

[16]  Richard G. W. Anderson,et al.  Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton , 2002, Journal of Cell Science.

[17]  L. de la Peña,et al.  Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line , 2002, Bioelectromagnetics.

[18]  L. Mirossay,et al.  Effects of static magnetic field on human leukemic cell line HL-60. , 2002, Bioelectrochemistry.

[19]  Catrin Bauréus Koch,et al.  Interaction between weak low frequency magnetic fields and cell membranes , 2003, Bioelectromagnetics.

[20]  E. Panzarini,et al.  Cell shape and plasma membrane alterations after static magnetic fields exposure. , 2009, European journal of histochemistry : EJH.

[21]  S. Tofani,et al.  Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. , 2003, Pharmacological research.

[22]  Tomasz Kuszewski,et al.  A cross-platform public domain PC image-analysis program for the comet assay. , 2003, Mutation research.

[23]  Céline Revenu,et al.  The co-workers of actin filaments: from cell structures to signals , 2004, Nature Reviews Molecular Cell Biology.

[24]  A. Torsello,et al.  Effects of 50 Hz electromagnetic fields on voltage-gated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death. , 2004, Cell calcium.

[25]  H. Namba,et al.  Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells. , 2004, Endocrinology.

[26]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[27]  A. Collins,et al.  The comet assay for DNA damage and repair , 2004, Molecular biotechnology.

[28]  A. Boninsegna,et al.  50-Hz extremely low frequency electromagnetic fields enhance cell proliferation and DNA damage: possible involvement of a redox mechanism. , 2005, Biochimica et biophysica acta.

[29]  Zhu Jie.  REAL TIME OBSERVATION ON CELLS IN DIFFERENT FIXED CONDITIONS AND LIVING CELLS IN BUFFER SOLUTION BY AFM , 2005 .

[30]  M. Li,et al.  Study of cell killing and morphology on S180 by ultrasound activating hematoporphyrin derivatives , 2003, Science in China Series C: Life Sciences.

[31]  Y. Liu,et al.  Static magnetic fields enhanced the potency of cisplatin on k562 cells. , 2010, Cancer biotherapy & radiopharmaceuticals.